February 14, 2026
WHO Slams US-Funded Hepatitis B Baby Vaccine Trial in Guinea-Bissau as Unethical
WHO halted a US-backed hepatitis B vaccine trial on 14,000 Guinea-Bissau newborns for ethical concerns. The trial delayed vaccination for some babies, risking their health. Guinea-Bissau’s government suspended the project amid public outrage. WHO emphasizes the birth dose is vital and proven to stop infection.